英国儿童非感染性慢性前葡萄膜炎管理中的共识领域
该研究于2017年6月至12月通过四轮改良德尔菲法两专家组流程,邀请儿童葡萄膜炎专家就儿童慢性前葡萄膜炎(CAU)管理条目达成共识,共识定义为同意率≥75%。38名受邀专家中26名(68%)参与,44个条目中23个达成共识,未达成共识的领域包括就诊时管理、重症患儿全身及眼周激素使用和甲氨蝶呤以外的传统激素节约型免疫抑制剂的作用。
要点
- 38名受邀专家中26名(68%)参与,第1至3轮应答率100%,第4轮92%。
- 44个条目中23个达成共识,共识定义为同意率≥75%。
- 未达成共识的领域包括就诊时管理、重症患儿全身及眼周激素使用和甲氨蝶呤以外的传统激素节约型免疫抑制剂的作用。
核心结论
- 群体层面管理不确定性的领域(以未达成共识为标志)反映了证据基础特别薄弱的领域。
- 研究结果确定了未来研究的关键领域,以确保改善这种致盲性儿童眼部炎症性疾病的结果。
研究设计与样本
- 研究于2017年6月至12月间进行四轮、两专家组的改良德尔菲共识流程。
- 通过多来源(包括多中心网络儿童眼部炎症组)确定儿童葡萄膜炎专家并邀请参与。
- 专家被询问是否同意源自现有幼年特发性关节炎葡萄膜炎(JIA-U)管理指南的条目外推至所有CAU患儿人群。
- 共识定义为同意率≥75%的受访者。
主要发现
- 38名受邀专家中26名(68%)参与,第1至3轮应答率为100%,第4轮为92%。
- 44个条目中23个达成共识。
- 未达成共识的条目包括就诊时管理、重症患儿全身及眼周激素使用和甲氨蝶呤以外的传统激素节约型免疫抑制剂的作用。
关键数值与推荐
- 共识定义为同意率≥75%的受访者。
- 44个条目中23个达成共识。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: There is a paucity of high-level evidence to support the management of childhood uveitis, particularly for those children without juvenile idiopathic arthritis uveitis (JIA). We undertook a modified Delphi consensus exercise to identify agreement in the management of chronic anterior uveitis (CAU), the most common manifestation of childhood disease. METHODS: A four-round, two-panel process was undertaken between June and December 2017. Paediatric uveitis specialists identified through multiple sources, including a multicentre network (the Paediatric Ocular Inflammation Group), were invited to participate. They were asked whether they agreed with items derived from existing guidelines on the management of JIA-U when extrapolated to the population of all children with CAU. Consensus was defined as agreement greater than or equal to 75% of respondents. RESULTS: 26 of the 38 (68%) invited specialists participated with the exercise, and response rates were 100% for rounds one to three, and 92% for round four. Consensus was reached on 23 of the 44 items. Items for which consensus was not reached included management at presentation, use of systemic and periocular steroids for children with severe disease and the role of conventional steroid sparing immunosuppressants beyond methotrexate. CONCLUSION: The areas of management uncertainty at the level of the group, as indicated by absence of consensus, reflect the areas where the evidence base is particularly poor. Our findings identify the key areas for the future research needed to ensure better outcomes for this blinding childhood ocular inflammatory disorders.
引用
- Solebo AL, Rahi JS, Dick AD, et al. Areas of agreement in the management of childhood non-infectious chronic anterior uveitis in the UK. Br J Ophthalmol. 2019. PMID: 31048286. doi:10.1136/bjophthalmol-2018-313789
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。